CD274 and cancer: The comparison of the [89Zr]Zr-DFO-KN035 and [18F]FDG PET imaging of patients with PD-L1-negative and -positive cancer patients indicated that the KN035 antibody had good specific targeting for the PD-L1 molecule in vivo.